Onderneming Enzychem Lifesciences Corporation
Aandelen
A183490
KR7183490002
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1.959 KRW | -11,56% | -2,05% | +7,76% |
Vakgebied
Aantal werknemers: 113
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Bio - Maintenance
53,8
%
| - | - | 40 927 | 53,8 % | - |
Drug Substance Other Product
45,0
%
| 25 630 | 96,2 % | 34 181 | 45,0 % | +33,36% |
Health Functional Food Product
1,2
%
| 1 007 | 3,8 % | 931 | 1,2 % | -7,58% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
93,3
%
| 23 868 | 89,6 % | 70 907 | 93,3 % | +197,08% |
Overseas
6,7
%
| 2 770 | 10,4 % | 5 132 | 6,7 % | +85,30% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gi-Young Sohn
CEO | Chief Executive Officer | 62 | 01-06-12 |
Do-Hyeon Jo
COO | Chief Operating Officer | 49 | 21-10-16 |
Myung-Hwan Kim
BRD | Director/Board Member | 67 | 01-06-15 |
Jae-Yong Lee
BRD | Director/Board Member | 62 | 01-04-11 |
Hwang-Bae Kang
AUD | Comptroller/Controller/Auditor | 58 | 30-03-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gi-Young Sohn
CEO | Chief Executive Officer | 62 | 01-06-12 |
Hye-Kyung Kim
BRD | Director/Board Member | 66 | 01-07-12 |
Jae-Yong Lee
BRD | Director/Board Member | 62 | 01-04-11 |
Myung-Hwan Kim
BRD | Director/Board Member | 67 | 01-06-15 |
Do-Hyeon Jo
COO | Chief Operating Officer | 49 | 21-10-16 |
Chang-Ki Hong
BRD | Director/Board Member | 87 | 26-03-19 |
Hye-Young Oh
BRD | Director/Board Member | 68 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 85 065 562 | 74 031 725 ( 87,03 %) | 0 | 87,03 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,76% | 122 mln. | |
+30,38% | 684 mld. | |
+26,51% | 568 mld. | |
-4,36% | 361 mld. | |
+19,30% | 329 mld. | |
+3,73% | 284 mld. | |
+16,70% | 240 mld. | |
+8,78% | 208 mld. | |
-7,93% | 200 mld. | |
+7,68% | 166 mld. |
- Beurs
- Aandelen
- Koers A183490
- Onderneming Enzychem Lifesciences Corporation